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ABSTRACT 
Objective:  Diabetes mellitus linked to severe macrovascular and the microvescular complications. Diabetic 
peripheral neuropathy is the challenging complication of the diabetes mellitus, which is linked to the morbidity, 
mortality, and big economic burden. We determined the frequency of peripheral neuropathy in newly diagnosed 
cases of type II diabetes mellitus. 
Materials & Methods:  The current descriptive Cross Sectional study took place in Services Institute of Medical 
Sciences, Lahore, From June 2014 to January 2015. All the patients, those were newly diagnosed with diabetes 
mellitus, aged 30-60 years and both genders were included. Detailed history regarding diabetes was taken. 
Patients underwent for the evaluation of peripheral neuropathy by taking physical examination, previous history 
and vibration perception test. All the data was recorded in the Proforma. 
Results:  Total 150 cases were studied, out of them, 42.67% were aged 30-45 years while 57.33% were in the age 
range of 46-60 years and their overall mean age was 46.35 ± 9.52 years. Males were 54.0% and females were 
46.0%. Frequency of peripheral neuropathy for newly diagnosed type II diabetic subjects was noted 20.67%, with 
insignificant association of age and gender. 
Conclusion:  It was concluded that the peripheral neuropathy was 20.67% among patients newly diagnosed with 
diabetes mellitus. 
Key Words:  Newly diagnosed type II diabetic patients, Peripheral neuropathy. 
 
INTRODUCTION 
Diabetes Mellitus (DM) is a medical condition with 
Hyperglycemia and metabolic disorder. It is a highly 
frequent endocrine condition and a major health 
problem. Above 0.22 billion people globally are 
diabetic.
1
 Pakistan alone presently accounts for 
6,200,000 diabetic cases and it is estimated that by 
until 2025. This figure will be nearly two times the 
current figure reaching 11.6 million individuals,
2
 and 
> 87 thousands occurred in Pakistan due to diabetes.
3
 
Neuropathy remains a most common complication for 
diabetes, distressing around 50% individual with 
diabetes.
4
 Neuropathy is a key factor of elevated 
mortality and morbidity, and is correlated with time 
period of hyperlipidemia, diabetes, and poor 
management of diabetes.
5
 It is more frequent among 
cases of prolonged diabetes duration and  poor 
glycemic control and its progress may be cause of  
lower extremity amputation.
6
 Several  metabolic 
irregularities as advanced glycosylation accumulation 
end products/sorbitol, raised oxidative stress along 
with nerve ischemia and weak repair mechanisms may 
be cause of the neuropathy development.
6,7
 
 The term diabetic neuropathy is expressed as signs 
and symptoms of impaired nerve functions in diabetic 
subjects following the exclusion of other causes. This 
complication remains frequent and can possibly lead to 
limb amputation, foot ulceration, joint deformity and 
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muscle atrophy.
8
 Previous studies are of the view that 
yet in freshly diagnosed subjects with type 2 diabetes 
(T2DM) with poor management of diabetes, frequency 
of micro-vascular complications is much greater than 
those with average management of diabetes. Thus, 
strong management of diabetes is helpful, even in 
freshly diagnosed T2DM to avoid and minimize the 
incidence of complications.
9
 
 A recent study recorded 16.8% cases of the newly 
diagnosed type II diabetes mellitus with peripheral 
neuropathy.
1
 Another study recorded these findings in 
29% of the cases.
10
 The rationale of this study is that, 
no data is available in our local population to address 
this issue. The results of the current study will clarify 
the above variation in our targeted population and also 
record the exact frequency, it will be helpful for the 
newly diagnosed type II diabetics and physicians as 
well for early administration of the morbidity. 
 
MATERIALS AND METHODS 
Study Design 
This descriptive cross Sectional study was carried out 
in the Services Institute of Medical Sciences, Lahore, 
From June 2014 to January 2015. 
 
Data Collection 
Sample size of 150 subjects was calculated with a 6% 
margin of error, 95% confidence level and taking 
expected %age of peripheral neuropathy i.e. 16.8%
1
 in 
newly diagnosed type II diabetics. Well-versed 
consent was taken from every subject. Detailed 
medical history and clinical examination were done. 
All patients underwent the evaluation process of 
peripheral neuropathy. Peripheral neuropathy was 
defined as the condition of impaired or diseased nerves 
that convey messages to the spinal cord and brain from 
the other body organs and vice versa. Diabetes 
mellitus was defined as those cases diagnosed as 
diabetic in previous 6 months and having a FPG level 
> 126 mg/dl. All the data in addition to 
presence/absence of peripheral neuropathy was 
recorded by the researcher on a pre-designed 
Performa. 
 
Inclusion Criteria 
All newly diagnosed cases of diabetes mellitus from 
last 6 months, aged 30-60 years and both genders were 
included. 
 
Exclusion Criteria 
All those subjects with neuropathy because of other 
factors, i.e. hereditary, drugs, autoimmune 
(acute/chronic, relapsing polyneuropathy) and subjects 
with systemic disorders such as chronic kidney 
dysfunction, Vitamin-B12 deficiency, hypothyroidism, 
hepatic disease, (AST/ALT > 40IU) vasculitis, 
malignancy, or leprosy (on the medical record and 
history) and not willing to participate in this study 
were excluded. 
 
Data Analysis 
The data analysis was carried out by SPSS version 
16.0. Mean ± SD were computed for quantitative 
variable such as age, FPG. Frequencies and 
percentages calculation were done for qualitative 
variable such as gender and peripheral neuropathy in 
freshly diagnosed cases of T2DM. Stratification for 
age, gender and FPG was recorded to address the 
effect modifiers. The Chi-square test was applied. 
A p-value < 0.05 was considered as significant. 
 
RESULTS 
Overall, 150 subjects fulfilling the inclusion criteria 
were registered to establish the frequency of 
neuropathy in freshly diagnosed cases of T2DM. 
According to age distribution; 42.67% subjects were 
aged 30 – 45 years while 57.33% subjects were in the 
age range of 46 – 60 years. The mean age of all the 
subjects was 46.35 ± 9.52 years. Gender distribution 
showed 54.0% males and 46.0% females. Mean FPG 
levels were recorded as 154.49 ± 15.84 (Table 1). 
 Frequency of peripheral neuropathy in freshly 
diagnosed cases of T2DM was recorded in 20.67% 
 
Table 1:  Age groups and gender of patients n = 150. 
 
Variables No. of Patients % 
Age Groups   
30-45 64 42.67.0% 
46-60 86 57.33.0% 
Total 150 100.0% 
Gender    
Males 81 54.0% 
Females 69 46.0% 
Total 150 100.0% 
Age (Mean ± SD) 46.35 ±9.52 years 
PGF (Mean ± SD) 154.49 ± 15.84 
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(n = 31) while 79.33% (n = 119) patients had no 
findings of peripheral neuropathy (Table 2). 
 
Table 2: Peripheral neuropathy among newly 
diagnosed cases of type ii diabetes mellitus 
(n = 150). 
 
Peripheral Neuropathy No. of Patients % 
Yes   31 20.67 
No 119 79.33 
Total 150 100 
 On stratification for gender and age was recorded 
to address the effect modifiers, and there was no 
significant association found according to age and 
gender, p-values were quite insignificant (Table 3). 
 
Table 3: Peripheral neuropathy according to age and 
gender (n = 150). 
 
Effect Modifiers  
Peripheral Neuropathy P 
value Yes No 
Age 
groups  
30 – 45 15 49 
0.461 
46 – 60 16 70 
Gender  
Male 17 63 
0.852 
Female 14 56 
 
DISCUSSION 
Diabetes mellitus (DM) is a highly frequent endocrine 
condition and a major health problem. DM is 
correlated with high-risk complications, mainly micro 
and macro vascular complications. These 
complications of DM include neuropathy, retinopathy, 
and nephropathy. Diabetic neuropathy remains a 
highly frequent complication of DM. This study was 
designed with the view that little data is available in 
our local population newly diagnosed with diabetes 
mellitus to address this issue while the international 
studies are also showing a significant variation; 
however the results of this study will clarify the 
variation in our targeted population and also record the 
exact frequency. In this study frequency of neuropathy 
among freshly diagnosed cases of T2DM was recorded 
in 20.67%. Consistently Gill HK et al
11
 conducted 
similar studies on newly diagnosed patients with DM 
and reported that the incidence of diabetic peripheral 
neuropathy was 29.2%, which is higher in contrast to 
this study. Inconsistently Iftikhar et al
12
 reported that 
diabetic peripheral neuropathy was 74.8%, which is 
very high as compare to this study, and this difference 
may because she had studied patients with prolonged 
duration of DM > 20 years and we studied patients 
only 6 months duration of diabetes. Khawaja et al
13
 
reported that the overall incidence of diabetic 
peripheral neuropathy was 39.5%. Other international 
studied showed incidence of diabetic peripheral 
neuropathy 45.00%, 31.9.00%, and 29.2.00% in Saudi 
Arabia, Iran, and United Arab Emirates.
14-16
 Ashok 
et al
17
 reported an incidence of 5.4% T2DM cases with 
neuropathy when diagnosis was made. These variances 
in the incidence of diabetic neuropathy in various 
studies in addition to our study can be explained 
because this study used electrophysiological and 
clinical studies, while others in addition to Ashok 
et al
17
 used a biothesiometer, which is relatively a less 
sensitive technique to detect neuropathy. A recent 
study recorded 16.8% of the freshly diagnosed T2DM 
with peripheral neuropathy.
1
 
 In current study patients’ mean age was 46.35 ± 
9.52 years; 53.33% subjects were males while 46.67% 
were females. Lakhiar et al
18
 reported that mean of 
patients was 45.19 years and according to gender 
distribution, 54.0% were males and 46.0% were 
females. Similarly Gill HK et al
11 
reported that the 
mean age of patients was 47.6  ± 10.2 years, and 59% 
were males and other were females. Iftikhar M et al 
12
 
reported that the mean age of study participants was 
49.52 ± 7.93 years. Ather et al
19
 reported an age range 
of 39 – 90 years with a mean age of (58 ± 11.2) in 
neuropathy subjects. In this study, we did not find any 
significant impact of age and gender on incidence of 
peripheral neuropathy. While inconsistently Gogia et 
al 
20
 reported that males were more effected in contrast 
to females, while Bansal et al
21
 found that there was no 
sex-significant differences. However a factor for the 
majority of patients with neuropathy when the 
diagnosis was done for DM in our patients can 
possibly be because of delay in the condition’s 
diagnosis, as a result of no knowledge and lack of 
financial resources. We are of the view that the 
frequency of diabetic peripheral neuropathy varies, 
however our findings are helpful for the newly 
diagnosed type II diabetics and physicians as well for 
timely management of the morbidity. 
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CONCLUSION 
It was concluded that the peripheral neuropathy was 
20.67% among newly diagnosed patients with diabetes 
mellitus. Freshly diagnosed cases of diabetes should 
be routinely examined and managed at early stage on 
the initial development of sing symptoms of peripheral 
neuropathy to decrease the morbidity and mortality. 
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